Clinical Trials Browser

Phase 2 × INDUSTRY × Adrenal Gland Diseases × Clear all

NCT05370521 2025-10-09

A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens

Phase 2 Terminated

27 enrolled 18 charts

Adrenal Gland Diseases, Polycystic Ovary Syndrome